Axsome Therapeutics, Inc. ($AXSM)
Filing Information
| Accession Number | 0001193125-26-174415 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 24, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
22,500
Total Value
$1,898,625.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Apr 22, 2026 | Exercise/Conversion | 7,500 | $70.73 | $530,475.00 | 7,500 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Apr 22, 2026 | Sale | 7,500 | $182.42 | $1,368,150.00 | 0 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Apr 22, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 23,710 | Direct | โ | View Details |